chrisvoncsefalvay/vaers-outcomes huggingface dataset:
My initial side effects were relatively common. Such as injection site soreness, swelling for a few days following the vaccination.; My initial side effects were relatively common. Such as injection site soreness, swelling for a few days following the vaccination.; I have had incontrollable hunger, cravings.; I have had incontrollable hunger, cravings.; Since the vaccination I have gained 8lbs.; This is a spontaneous report from a contactable consumer, the patient. A 43-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on an unknown date in Jul2021 as a single dose for COVID-19 immunisation. Medical history included permanent sterilization (female sterilization), latex allergy and penicillin allergy. The patient did not receive any other medicines within two weeks prior to the COVID-19 vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 05Jul2021, the patient experienced initial side effects which were relatively common such as injection site soreness, swelling for a few days following the vaccination. 72 hours after the vaccination the patient had uncontrollable hunger, cravings. The patient was not pregnant. (Permanent sterilization). Since the vaccination the patient had gained 8 lbs. It was so severe that the patient thought that it should be reported. Perhaps other people were experiencing the same side effect. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event vaccination site soreness, swelling, uncontrollable hunger cravings and weight gain were unknown at the time of this report.   The lot number for BNT162b2, were not provided and will be requested during follow up.
Redness to right thigh, provider ordered KEFLEX 125/5ml and BENADRYL 12.5/5ml.
Patient complained of pain towards the back of her upper arm and in her shoulder joint, not at the injection site. The pain started after injection, seemed to subside after several more days, but has recurred often waking her up at night. The pain responds to anti-inflammatories and she did not have any precious history of this pain.
Information has been received from a doctor of pharmacy student concerning a female patient, who on 13-MAY-2011 was vaccinated with a 0.65ml dose of ZOSTAVAX (Merck) (Lot # 669867/0361AA EXP 09-JUN-2012) SQ. On an unspecified date the patient experienced twitching in her jaw. There were no Lab diagnosis/studies performed. The patient did not seek medical attention. It was reported that the patient had not received treatment for the adverse event. At the time of the report, the patient had not recovered. No further information is available.
This spontaneous report as received from a pharmacist refers to a patient of unknown age and gender. There were no concomitant medications, concurrent conditions and medical history reported. Pharmacist reported than an unspecified patient, who received all 3 doses series of the GARDASIL (route and site of administration, dose, lot# and expiration date were not reported) on unspecified dates in either 2012 or 2013, received 2 more doses of either GARDASIL or GARDASIL 9 (route and site of administration, dose, lot# and expiration date were not reported) on unspecified dates in 2015. Pharmacist could not confirm which vaccine the patient received for doses 4 and 5. There was no adverse effect reported. Additional information has been requested.
On the December 25th, I woke up feeling exhausted, congested, and achy. The symptoms worsened throughout the next two days. On the 27th, I took a COVID-19 test. It was positive. I went to urgent care and asked them to retest me for COVID-19. The results were positive. The doctor prescribed LAGEVRIO and promethazine, but I haven't picked them up yet. He told me to stay well hydrated and to get plenty of rest.
Tachycardia - Heart Rate between 120-140 for about a 4-5 hour timeframe. About 15 hours post dose.
Date the vial was initially stored was on 31 Jan 2022 and patient administered vaccine on 31 Mar 2022; Patient administered vaccine on 31 Mar 2022 and thaw expiration date was on 02 Mar 2022; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient administered vaccine on 31 Mar 2022 and thaw expiration date was on 02 Mar 2022) and PRODUCT STORAGE ERROR (Date the vial was initially stored was on 31 Jan 2022 and patient administered vaccine on 31 Mar 2022) in a 37-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045L21A) for COVID-19 vaccination.     No Medical History information was reported.    On 31-Mar-2022 at 10:18 AM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 31-Mar-2022 at 10:18 AM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient administered vaccine on 31 Mar 2022 and thaw expiration date was on 02 Mar 2022). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Date the vial was initially stored was on 31 Jan 2022 and patient administered vaccine on 31 Mar 2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient administered vaccine on 31 Mar 2022 and thaw expiration date was on 02 Mar 2022) and PRODUCT STORAGE ERROR (Date the vial was initially stored was on 31 Jan 2022 and patient administered vaccine on 31 Mar 2022) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication were reported.  It was reported that patient received doses after the beyond use date.Date vials were  initially stored in refrigerator was reported as  31 Jan 2022.  It was reported that the thaw expiration date was on 02 Mar 2022, and the total doses given were 20 doses of 15 vials used.  It was reported that the vials had not undergone any temperature excursion.  No treatment medication were reported.
Patient reports a raised rash on 1/2 of his body.  Rash comes and goes and is more severe at times than others.  Patient has used a topical benadryl product along with zyrtec 10mg orally and famotidine 20mg orally
itching on arms and neck, no rash noticed, Benadryl 25mg PO given, notify Dr. Allergist on call, symptoms resolved, pt discharged to home
felt very weak; For 3 days, I felt very sick.; pain everywhere; arm hurt; some parts of my body hurt so much; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of ASTHENIA (felt very weak), ILLNESS (For 3 days, I felt very sick.), PAIN (pain everywhere), PAIN IN EXTREMITY (arm hurt) and MYALGIA (some parts of my body hurt so much) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included COVID-19 from 16-Jan-2021 to 09-Feb-2021.    On 21-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ASTHENIA (felt very weak), ILLNESS (For 3 days, I felt very sick.), PAIN (pain everywhere), PAIN IN EXTREMITY (arm hurt) and MYALGIA (some parts of my body hurt so much). At the time of the report, ASTHENIA (felt very weak), ILLNESS (For 3 days, I felt very sick.), PAIN (pain everywhere), PAIN IN EXTREMITY (arm hurt) and MYALGIA (some parts of my body hurt so much) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Antibody test: positive (Positive) Blood work came out with positive antibodies.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.   Treatment information was not provided.
fever; This case was reported by a consumer via call center representative and described the occurrence of fever in a 54-year-old female patient who received Flu Seasonal QIV Dresden (Influenza vaccine Quadrivalent unspecified season) for prophylaxis.   Previously administered products included Shingrix (1st dose received on 23rd July 2020). Concurrent medical conditions included allergic reaction to wasp sting, allergy to chemicals and asthma. Concomitant products included prednisone.   On an unknown date, the patient received Influenza vaccine Quadrivalent unspecified season. On an unknown date, unknown after receiving Influenza vaccine Quadrivalent unspecified season, the patient experienced fever. On an unknown date, the outcome of the fever was recovered/resolved.   It was unknown if the reporter considered the fever to be related to Influenza vaccine Quadrivalent unspecified season.  Additional details were provided as follows: The age at vaccination was not reported. The patient had a history of chemical allergies and asthma. On 9th September 2020, the patient was stung by a wasp on her right shin and she had a bad reaction to the wasp sting and had finished a steroid pack treatment of 4 mg of prednisone last on night of 19th September 2020. The patient got the flu vaccines and several times, but not every time the patient experience a fever that resolved. The reporter consented to follow up. This case has been linked with US2020AMR197139 and US2020193841 reported by same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2020AMR197139:same patient Shingrix 1st dose US-GLAXOSMITHKLINE-US2020193841:same patient Shingrix 2nd dose
got the 2nd booster shot and asked if it is safe to take the acetaminophen 325mg for pain; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP), Program ID:  The reporter is the patient.  A male patient received BNT162b2 (BNT162B2), as dose number unknown (booster), single (Batch/Lot number: unknown) for covid-19 immunization. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Primary Immunization series complete unknown manufacturer), for Covid-19 Immunization; Covid-19 vaccine (Dose Number Unknown (BOOSTER), unknown manufacturer), for Covid-19 Immunization. The following information was reported: PAIN (non-serious), outcome "unknown", described as "got the 2nd booster shot and asked if it is safe to take the acetaminophen 325mg for pain".  Additional Information: Patient reported that he got the 2nd booster shot and asked if it is safe to take the acetaminophen 325mg for pain. confirmed he hadn't taken the drug yet and wanted to confirm before taking it. Caller mentioned he went back from the hospital. No transfer (Call got disconnected) Created Form. Caller refused to provide phone number attempted to provide  phone number but caller refused and decided to call his doctor instead.   The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Client become diaphoretic, grey in color, and nauseated approximately 1 minute after administration of the Hepatitis A vaccine. Client attempted to walk from chair to the exam table to lay down and had to lay down in the middle of the hallway due to becoming dizzy and lightheadeded. Client reported ringing in his ears and numbness to the right upper extremity. Good circulation to right upper extremity noted.
COVID Disease after Bivalent Booster; This spontaneous case was reported by a patient family member or friend and describes the occurrence of COVID-19 (COVID Disease after Bivalent Booster) in an adult male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Sep-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. In November 2022, the patient experienced COVID-19 (COVID Disease after Bivalent Booster). At the time of the report, COVID-19 (COVID Disease after Bivalent Booster) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In November 2022, SARS-CoV-2 test: Positive.         No concomitant medications were reported.  No treatment medications were reported.   This case was linked to MOD-2022-673505 (Linked Report).   Reporter did not allow further contact; Sender's Comments:  MOD-2022-673505:Wife case
Ocular hyperaemia; Nasopharyngitis; chest discomfort; sleep disorder; sinus congestion; dysphonia; rhinorrhoea; chills. This non serious case was extracted  from the VAERS database via QSCAN on 11 March 2009 (reference number 296653). A 67 year old female patient received Fluzone SV 2007-2008 (lot number U2493AA) intramuscularly on 08 November 2007 at 2:50 PM. By 5:15 PM the patient's voice became hoarse, chest tight, mucus, eyes were red and mucusy, cold, chills, runny nose, and sinus congestion. She slept off and on. She went to work and came home after one hour and slept. She felt better by 6:30 PM and had recovered. List of Documents held by Sender: none.
restless; This spontaneous case was reported by a consumer and describes the occurrence of RESTLESSNESS (restless) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In April 2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In April 2021, the patient experienced RESTLESSNESS (restless). At the time of the report, RESTLESSNESS (restless) had resolved.            Concomitant medication of the patient was not reported.  In the morning, of getting the second vaccine, the patient did a prep. The patient went to work, got home and was so restless. The patient spent 3 hours finally building a gym in garage (the patient already had everything and was just procrastinating about ever putting it together). On 9:30, the patient needed a shot of whiskey, had to go to bed and was not going to without it.  No treatment information was provided by the reporter.   This case was linked to MOD-2021-339560 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 05-Oct-2021: Outcome of the event was updated to resolved as per the response from the patient.
Initial and follow up information has been received from a physician concerning a 14 month old male patient, with eczema, atopic dermatitis and an egg, milk and dairy allergy, who on 4/28/04 at 10:00 AM was vaccinated SC with a first dose of MMR (lot # 0955N/646744). Concomitant vaccination included a first SC dose of varicella virus vaccine live (lot # 646363/0574N). On 5/18/04 (previously reported as twenty three days after vaccination) the patient developed mumps. The patient had a low grade fever (exact temperature reading not provided) and sought unspecified medical attention but was not hospitalized. He presented with left side parotid swelling and pain which had worsened on 5/19/04. The patient's amylase was 392, ESR was 65, platelets were increased (463), WBC 16.9, hemoglobin was 11.9, and hematocrit was 34.4. It was reported that the patient recovered on 5/24/04. Additional information is not expected.
Within 6 hours post vax, the pt developed a fever of 103.8F and a local reaction to site 3 X 4 inch red area (site not specified). File to be completed.
Neck lyph nodes swelling, under chin to collarbones, pancreatitis, never had prior occurance. Felt like liver was on fire, similar to gallbladder pain. I do not have a gallbladder, fatique
Red and hot to touch on left leg. Treatment: Local care, warm soaks, Benadryl 1 tsp every 4-6 hours.
Patient received 1st vaccine March 9th, 2021. He returned today and was given a second vaccine. He did not have an appointment and was given a 2nd vaccination . He handed his card afterwards which revealed that a 1st one on 3/9/21, making his 2nd one too soon.
This spontaneous report as received from a pharmacist refers to a patient of unknown age and gender. No information regarding the patient's pertinent medical history, concomitant medications, drug reactions, or allergies was provided. On 16-OCT-2017, the patient was vaccinated with ZOSTAVAX 19400 plaque-forming units (PFU) (dose was not provided; lot # M042854, expiration date: 18-JAN-2018), reconstituted with sterile diluent (manufacturer unknown) (lot# N000383, expiration date: 28-JUN-2019), given by intramuscular instead of subcutaneous route. The pharmacist stated, that ZOSTAVAX and sterile diluent (manufacturer unknown) did not undergo a temperature excursion. No adverse effects occurred.
A spontaneous report was received from a patient who received COVID-19 Vaccine (mRNA-1273) and developed itching, erythema and very mild induration. The patient's medical history was not provided.  No relevant concomitant medications were reported. On 26 Dec 2020, 10 days prior to the onset of events, the patient received the first of two planned doses of mRNA-1273 intramuscularly for prophylaxis of COVID-19 infection. On 05 Jan 2021, the patient was  experiencing itching, erythema and very mild induration. No treatment information was provided. Action taken with mRNA-1273 was unknown. The outcome of the events, itching, erythema, and very mild induration, were considered unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Crying excessively greater than three hours, hot to touch, abdomen gurgling, loose mucous bowel movement, decreased appetite
Initial report was received 16 June 2009 from a health care professional. An 18-month old patient had received an injection of DAPTACEL and an injection of IPOL (lot numbers, routes, sites and dates of administration not reported) and an unspecified amount of time later, they developed a 5 cm erythematous area surrounding each injection site and erythematous papules on their arms and trunk. They were evaluated by their physician on 16 June 2009. The patient had not recovered from the event and no further information was provided at the time of the report. Documents held by sender: None.
headache/sharp shooting pain on the left side of her head; feeling sensational on the left side of her face; mouth is being swelling; cuts on her cheeks and on her tongue; extremely tired; sick; This is a spontaneous report from a contactable consumer (patient). A 35-year-old female patient received the second dose of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, lot number and expiry date unknown), via an unspecified route of administration, administered in the right arm on 07May2021 as a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient previously received the first dose of BNT162B2 in Apr2021 in the right arm for COVID-19 immunization. The patient called to know if there was any research about people having any adverse effects with the shot. The patient stated that she went to the emergency room and saw the doctor and was hospitalized since she had a very several headache which started on 10May2021, over 6 days that has not gone away with medication (unspecified medication). The patient also stated that she has taken a shot (unspecified) for the headache and it worked for a little bit of time and the headache came right back. The headache is almost so bad it's giving birth, it's terrible. The headache has not been letting her take care of her children so she wants to know if there are researches that could help her situation. This happened right after she took a shot and does not have a history of headache ever. She has always been very healthy and so she believes it is the shot that is causing her the problem. She has a sharp shooting pain on the left side of her head. She has feeling sensational on the left side of her face (as reported), her mouth is being swelling, has cuts on her cheeks and on her tongue from swallowing. The patient stated that overall she is extremely tired and a lot of bad things has been happening ever since she took the shot over a week ago and she has been sick the whole time. The outcome of the events was unknown.   Information about lot/batch number has been requested.
STUFFINESS FEELING LIKE A COLD; SORE SHOULDER; This spontaneous report received from a patient concerned a male of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: MSL-319813 expiry: UNKNOWN) dose was not reported, administered on 05-MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 05-MAR-2021, the subject experienced sore shoulder. On 06-MAR-2021, the subject experienced stuffiness feeling like a cold. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered with sequelae from stuffiness feeling like a cold on 08-MAR-2021, and sore shoulder on 09-MAR-2021. This report was non-serious.
Information has been received from a office assistant concerning a 23 year old female with drug hypersensitivity to aspirin who on 11-JUN-2007 was vaccinated IM with a 0.5 ml first dose of Gardasil (lot # 657868/0523U). Concomitant therapy included ethinyl estradiol (+) ferrous fumarate (+) Norethindrone acetate (LOESTRIN 24 FE). On 11-JUN-2007 in the evening, the patient experienced fever 100-101F, stiff limbs, joint aches and pains, and swollen, sore, blistery, and peeling lips. Unspecified medical attention was sought. The patient's fever 100-101F and stiff limbs, joint aches and pains, and swollen, sore, blistery, and peeling lips persisted. There were no laboratory or diagnostic tests performed. Additional information has been requested.
Initial report received from healthcare professional (pharmacist) on 17 February 2014. A 40-year-old male patient had received a dose of FLUZONE, (batch number UH908AA, dose number not reported) intramuscularly in left deltoid on 28 January 2014. The patient's illness at time of vaccination and pre-existing physician diagnosed allergies, birth defects, medical conditions were not provided. On 11 February 2014, the patient presented injection site pain for about 5 hours after injection, and left deltoid area hurt whenever he moved his arm. The patient had stopped, but reoccurred 2 weeks later. No laboratory investigations were performed and corrective treatments were not reported. At the time of this report, the patient had not recovered. Documents held by sender: none.
Systemic: Allergic: Itch (specify: facial area, extremeties)-Medium, Systemic: Dizziness / Lightheadness-Severe, Systemic: Tachycardia-Medium, Additional Details: ITCHY SENSATION AROUND FACE AND MOUTH. GAVE 50MG BENADRYL. PT RECOVERED WITHIN HALF HOUR.
This patient requested a flu shot on 1/12/2022 and received one at our vaccine clinic. It wasn't until after he left that we saw in his chart that he had received a flu shot on 9/13/2021. We spoke with dad and he said they forgot that he already had one.